Examining Adolescent Assessment, Feedback, Incentive, and Exchange (AFIX)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 91
- 试验地点
- 4
- 主要终点
- Change in Vaccination Rate: HPV vaccine initiation among 11-12 year olds
研究概览
简要总结
The North Carolina Immunization Branch will evaluate the use of the CDC program to improve adolescent vaccination practices (called Assessment, Feedback, Incentives, and eXchanges, or AFIX). This evaluation is the first of its kind in the nation and may have a profound impact on prevention.
AFIX has four major components: 1) Assessment of a provider's current immunization practices and vaccination levels, 2) Feedback of the assessment results and strategies to improve coverage levels, 3) Incentives to improve coverage levels, and 4) eXchange of information and resources necessary to facilitate improvement.
This program will evaluate the effectiveness of AFIX visits on affecting provider practices to increase adolescent (age 11-18) immunization. Visits include discussion of that practice's immunization rates and strategies for improving rates. The investigators will compare the changes, from baseline to 5 months, in immunization for practices receiving virtual visits (webinars), in-person visits, and no visits (control group). Thirty practices will be randomly assigned to each intervention type. The main outcomes of this study are practice-wide uptake rates of several adolescent vaccines (Tdap, HPV, and MCV4) as well as pre- and post-AFIX visit surveys focusing on recall tactics utilized by each practice. Data will be collected on practices with at least 200 adolescent patients (note: there is no patient-level data collected in this study).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Pediatric and/or family practices participating in the North Carolina Immunization Program
- •A minimum of 200 active adolescent patients
排除标准
- 未提供
结局指标
主要结局
Change in Vaccination Rate: HPV vaccine initiation among 11-12 year olds
时间窗: Baseline and 5 months follow-up
We will gather practice-specific rates of coverage for adolescents (age 11-12) for the first dose of human papillomavirus (HPV) vaccine at baseline and 5 months follow-up.
次要结局
- Change in Vaccination Rate: HPV vaccine initiation among 13-18 year olds(Baseline and 5 months follow-up)
- Change in Vaccination Rate: Tdap vaccine among 11-12 year olds(Baseline and 5 months follow-up)
- Change in Vaccination Rate: Tdap vaccine among 13-18 year olds(Baseline and 5 months follow-up)
- Change in Vaccination Rate: Meningitis vaccine among 11-12 year olds(Baseline and 5 months follow-up)
- Change in Vaccination Rate: Meningitis vaccine among 13-18 year olds(Baseline and 5 months follow-up)
- Change in Vaccination Rate: HPV vaccine completion among 11-12 year olds(Baseline and 5 months follow-up)
- Change in Vaccination Rate: HPV vaccine completion among 13-18 year olds(Baseline and 5 months follow-up)
